Cargando…
Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles
OBJECTIVE: The aim of this study was to establish criteria that would indicate whether fertility preservation therapy would likely be safe for patients aged 40 years or less with endometrioid endometrial cancer based on their DNA methylation profile. METHODS: Forty-nine fresh-frozen tissue samples f...
Autores principales: | Hirano, Takuro, Arai, Eri, Fujimoto, Mao, Nakayama, Yuji, Tian, Ying, Ito, Nanako, Makabe, Takeshi, Yamagami, Wataru, Susumu, Nobuyuki, Aoki, Daisuke, Kanai, Yae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634101/ https://www.ncbi.nlm.nih.gov/pubmed/36047377 http://dx.doi.org/10.3802/jgo.2022.33.e74 |
Ejemplares similares
-
Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer
por: Makabe, Takeshi, et al.
Publicado: (2019) -
Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
por: Yamagami, Wataru, et al.
Publicado: (2018) -
Hypertriglyceridemia is Frequent in Endometrial Cancer Survivors
por: Hirasawa, Akira, et al.
Publicado: (2013) -
Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer
por: Banno, Kouji, et al.
Publicado: (2013) -
Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia
por: Inoue, Osamu, et al.
Publicado: (2016)